![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2022
Kayser, Sabine; Kramer, Michael; Martinez-Cuadron, David; Grenet, Justin; Metzeler, Klaus H.; Sustkova, Zuzana; Luskin, Marlise R.; Brunner, Andrew M.; Elliott, Michelle A.; Gil, Cristina; Marini, Sandra Casal; Racil, Zdenek; Cetkovsky, Petr; Novak, Jan; Perl, Alexander E.; Platzbecker, Uwe; Stoelzel, Friedrich; Ho, Anthony D.; Thiede, Christian; Stone, Richard M.; Roellig, Christoph; Montesinos, Pau; Schlenk, Richard F. und Levis, Mark J.
(2022):
Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study.
In: Haematologica, Bd. 107, Nr. 4: S. 836-843
2021
Witzens-Harig, Mathias; Viardot, Andreas; Keller, Ulrich; Wosniok, Julia; Deuster, Oliver; Klemmer, Jennifer; Geueke, Anne-Marie; Meissner, Julia; Ho, Anthony D.; Atta, Johannes; Marks, Reinhard; La Rosee, Paul; Buske, Christian; Dreyling, Martin H. und Hess, Georg
(2021):
The mTOR Inhibitor Temsirolimus Added to Rituximab Combined With Dexamethasone, Cytarabine, and Cisplatinum (R-DHAP) for the Treatment of Patients With Relapsed or Refractory DLBCL - Results From the Phase-II STORM Trial.
In: Hemasphere, Bd. 5, Nr. 10, e636